Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

Takuji Torimura, Hideki Iwamoto

Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0204

View: 9030 Download: 391 Web of Science: 42 Crossref: 41

Original Article

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea

Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jin Sil Seong, Kwang-Hyub Han, Do Young Kim

Clin Mol Hepatol. 2020;26(1):24-32. Published online May 20, 2019

DOI: https://doi.org/10.3350/cmh.2018.0065

View: 10136 Download: 305 Web of Science: 30 Crossref: 30

Review

Ultraselective conventional transarterial chemoembolization: When and how?

Shiro Miyayama

Clin Mol Hepatol. 2019;25(4):344-353. Published online April 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0016

View: 11692 Download: 566 Web of Science: 30 Crossref: 33

3

Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm

Min Jae Yang, M.D., So Yun An, M.D., Eun Joon Moon, M.D., Min Suk Lee, M.D., Joo An Hwang, M.D., Jae Youn Cheong, M.D., Je Hwan Won, M.D. Jai Keun Kim, M.D. Hee Jung Wang, M.D. Sung Won Cho, M.D.

Clin Mol Hepatol. 2009;15(4):474-485. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.474

View: 5509 Download: 45 Crossref: 4

4

A Case of Infiltrative Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis Successfully Treated by Transarterial Chemoembolization

Sun-Jung Myung, M.D., Jung-Hwan Yoon, M.D., Geum-Youn Gwak, M.D., Cheol Min Shin, M.D., Dong Won Ahn, M.D., Su Jong Yu, M.D., Ji-Won Yu, M.D., Soo-Jeong Cho, M.D., Jin Wook Chung, M.D. and Hyo-Suk Lee, M.D.

Clin Mol Hepatol. 2006;12(1):107-111. Published online January 1, 1970

View: 2999 Download: 22

3

Clinical Features of Liver Abscess Developed after Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma

Min Hyung Kim, M.D., Moon Seok Choi, M.D., Yong Sung Choi, M.D., Do Young Kim, M.D., Ji Min Lee, M.D. Seung Woon Paik, M.D., Joon Hyuek Lee, Kwang Cheol Koh, M.D., Byung Cheol Yoo, M.D., Dongil Choi, M.D. and Jong Chul Rhee

Clin Mol Hepatol. 2006;12(1):55-64. Published online January 1, 1970

View: 3518 Download: 42

1 |

Viewed By 5015	MAFLD: How is it different from NAFLD?
Viewed By 4843	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4792	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4496	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4467	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search